Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment
- PMID: 17916180
- DOI: 10.1111/j.1742-1241.2007.01268.x
Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment
Abstract
This study was aimed to investigate the relationship between plasma fibrinogen level and risk for cognitive decline and dementia in patients with mild cognitive impairment (MCI). Elderly patients with suspected cognitive impairment were screened and evaluated periodically. One hundred and eighty-five patients who met the criteria for MCI were enrolled. Blood coagulation functions and plasma fibrinogen levels were measured at baseline. Hyperfibrinogenaemia was defined as plasma fibrinogen > or =3.0 g/l. Global cognitive function was assessed serially with Mini-Mental State Examination (MMSE). The enrolled patients were followed for 2 years to observe if dementia was developed. There were 185 patients diagnosed as MCI, of which 17 (9.2%) deceased, 15 (8.1%) lost to follow-up, and 68 (36.8%) developed dementia during follow-up. Mean of MMSE score of the enrolled patients declined significantly during follow-up (22.0 +/- 3.0 vs. 18.1 +/- 5.8, p < 0.001). Patients with hyperfibrinogenaemia at baseline had greater MMSE decrement during follow-up than patients with normal fibrinogen level (-5.4 +/- 5.4 vs. -3.5 +/- 4.5, p < 0.05). Linear regression indicated that plasma fibrinogen level was associated with cognitive decline (R = 0.17, p < 0.05). Patients with hyperfibrinogenaemia had an increased risk for dementia and vascular dementia compared with patients with normal level of plasma fibrinogen (log rank test, p < 0.05). There was a trend that hyperfibrinogenaemia also increased risk for dementia of Alzheimer's type (p = 0.061). It can be concluded that plasma fibrinogen level may be associated with cognitive decline, and hyperfibrinogenaemia may increase risk for dementia in patients with MCI.
Similar articles
-
Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.J Neurol Sci. 2009 Sep 15;284(1-2):77-80. doi: 10.1016/j.jns.2009.04.018. Epub 2009 May 5. J Neurol Sci. 2009. PMID: 19419739
-
Alcohol consumption and transition of mild cognitive impairment to dementia.Psychiatry Clin Neurosci. 2009 Feb;63(1):43-9. doi: 10.1111/j.1440-1819.2008.01904.x. Psychiatry Clin Neurosci. 2009. PMID: 19154211
-
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.Int J Geriatr Psychiatry. 2006 Jun;21(6):550-5. doi: 10.1002/gps.1523. Int J Geriatr Psychiatry. 2006. PMID: 16642542
-
[The minimental state examination--an up-to-date review].Harefuah. 2006 Sep;145(9):687-90, 701. Harefuah. 2006. PMID: 17078433 Review. Hebrew.
-
Predictors of reversible mild cognitive impairment after stroke: a 2-year follow-up study.J Neurol Sci. 2005 Mar 15;229-230:21-5. doi: 10.1016/j.jns.2004.11.015. Epub 2004 Dec 28. J Neurol Sci. 2005. PMID: 15760615 Review.
Cited by
-
The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.J Cereb Blood Flow Metab. 2013 Aug;33(8):1251-8. doi: 10.1038/jcbfm.2013.76. Epub 2013 May 8. J Cereb Blood Flow Metab. 2013. PMID: 23652625 Free PMC article.
-
Inflammatory markers and imaging patterns of advanced brain aging in the general population.Brain Imaging Behav. 2020 Aug;14(4):1108-1117. doi: 10.1007/s11682-019-00058-y. Brain Imaging Behav. 2020. PMID: 30820858 Free PMC article.
-
Fibrinogen as a key regulator of inflammation in disease.Semin Immunopathol. 2012 Jan;34(1):43-62. doi: 10.1007/s00281-011-0290-8. Epub 2011 Oct 31. Semin Immunopathol. 2012. PMID: 22037947 Review.
-
Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.Neurobiol Aging. 2015 Feb;36(2):608-17. doi: 10.1016/j.neurobiolaging.2014.10.030. Epub 2014 Oct 31. Neurobiol Aging. 2015. PMID: 25475538 Free PMC article.
-
The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer's Disease.Front Neurosci. 2021 Jan 21;14:625844. doi: 10.3389/fnins.2020.625844. eCollection 2020. Front Neurosci. 2021. PMID: 33551734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous